Dubai Hospital, DHA, United Arab Emirates; Gulf Medical University, United Arab Emirates; Postgraduate Diabetes Education, Cardiff University, UK.
Department of Internal Medicine, Hospital Putrajaya, Putrajaya, Malaysia.
Diabetes Res Clin Pract. 2021 Mar;173:108674. doi: 10.1016/j.diabres.2021.108674. Epub 2021 Jan 23.
The DAR Global survey of Ramadan-fasting during the COVID-19 pandemic aimed to describe the characteristics and care in participants with type 2 diabetes (T2D) with a specific comparison between those <65 years and ≥65 years.
Participants were consented to answer a physician-administered questionnaire following Ramadan 2020. Impact of COVID-19 on the decision of fasting, intentions to fast and duration of Ramadan and Shawal fasting, hypoglycaemia and hyperglycaemia events were assessed. Specific analysis comparing age categories of <65 years and ≥65 years were performed.
Among the 5865 participants, 22.5% were ≥65 years old. Concern for COVID-19 affected fasting decision for 7.6% (≥65 years) vs 5.4% (<65 years). More participants ≥65 years old did not fast (28.8% vs 12.7%, <65 years). Of the 83.6%, participants fulfilling Ramadan-fasting, 94.8% fasted ≥15 days and 12.6% had to break fast due to diabetes-related illness. The average number of days fasting within and post-Ramadan were 27 and 6 days respectively, regardless of age. Hypoglycaemia and hyperglycaemia occurred in 15.7% and 16.3% of participants respectively, with 6.5% and 7.4% requiring hospital care respectively. SMBG was performed in 73.8% of participants and 43.5% received Ramadan-focused education.
During the COVID-19 pandemic, universally high rates of Ramadan-fasting were observed regardless of fasting risk level. Glycemic complications occurred frequently with older adults requiring higher rates of acute hospital care. Risk stratification is essential followed by pre-Ramadan interventions, Ramadan-focused diabetes education and self-monitoring to reduce and prevent complications, with particular emphasis in older adults.
DAR 全球在 COVID-19 大流行期间进行的斋月禁食调查旨在描述患有 2 型糖尿病(T2D)的参与者的特征和护理情况,并特别比较了<65 岁和≥65 岁的参与者。
在 2020 年斋月期间,征得参与者同意后,他们会回答医生管理的问卷。评估了 COVID-19 对禁食决定、禁食意愿和斋月及舍尔巴恩禁食持续时间、低血糖和高血糖事件的影响。对<65 岁和≥65 岁的年龄组进行了专门的分析比较。
在 5865 名参与者中,22.5%的人≥65 岁。由于 COVID-19 的担忧,7.6%(≥65 岁)的参与者改变了禁食决定,而<65 岁的参与者则为 5.4%。更多的≥65 岁的参与者没有禁食(28.8% vs 12.7%,<65 岁)。在满足斋月禁食条件的 83.6%的参与者中,94.8%的人禁食了≥15 天,有 12.6%的人因糖尿病相关疾病而不得不中断禁食。在斋月期间和斋月后,平均禁食天数分别为 27 天和 6 天,无论年龄大小。低血糖和高血糖的发生率分别为 15.7%和 16.3%,分别有 6.5%和 7.4%的人需要住院治疗。有 73.8%的参与者进行了 SMBG,43.5%的人接受了斋月相关的教育。
在 COVID-19 大流行期间,无论禁食风险水平如何,普遍都有很高的斋月禁食率。高血糖并发症经常发生,老年患者需要更高的急性住院治疗率。需要进行风险分层,然后进行斋月前干预、斋月相关糖尿病教育和自我监测,以减少和预防并发症,特别是在老年人中。